Screener / SEC EDGAR /CIK 0001809987 /10-K filed Feb 19, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Technology · Measuring Instruments

Mirion Technologies, Inc. MIR

Compare with peers Embed
FY2025 at a glance

Sales up 7.5%, free cash flow up to $106.9M

XBRL, from each 10-K
RevenueStatements
$925.4M from $860.8M in FY2024
FY2019FY2025
Net incomeStatements
$28.8M from -$36.1M in FY2024
FY2019FY2025
Free cash flowStatements
$106.9M from $50.3M in FY2024
FY2019FY2025
EPS (diluted)Statements
$0.11 from $-0.18 in FY2024
FY2019FY2025
Operating marginStatements
5.6% from 2.9% in FY2024
FY2019FY2025
Total debtStatements
$444.7M from $686.4M in FY2024
FY2019FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (42)
EPS (ttm)
0.11
Sales (ttm)
1.1B
Net income (ttm)
29.0M
Sales growth
+7.5%
EPS growth
-
Sales Q/Q
+24.5%
Free cash flow
168.0M
Gross margin
48.1%
Oper. margin
6.0%
Net margin
2.7%
FCF margin
15.6%
ROE
1.6%
ROA
0.8%
R&D / sales
4.2%
Dividend
-
Debt/Eq
0.25
Curr. ratio
3.02
Cash
408.7M
Op. cash flow (ttm)
209.6M
EBITDA
189.6M
EBITDA margin
20.5%
Net debt
35.3M
Quick ratio
2.51
Interest cover
1.22
ROIC
2.1%
FCF after stock pay
91.7M
Debt / FCF (years)
4.15
Goodwill / assets
52.2%
Tax rate
8.9%
Stock pay / sales
1.6%
Shares out.
272.9M
Shares Y/Y
+27.4%
Book / share
6.54
Cash / share
1.50
Sales / share
3.96
Asset turnover
0.31
Inventory turns
3.19
Days sales out.
72
Sales 3Y CAGR
+8.8%
Sales 5Y CAGR
+12.7%
Employees
3,281
Sales / employee
329K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2019 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 925.4M +13.2% a year Net income 28.8M
FY2019 revenue 440.1M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-22-004286 FY2019 net income -122.0M · NetIncomeLoss, 0001628280-22-004286 440.1M FY2019 FY2020 revenue 478.2M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-23-005646 FY2020 net income -119.1M · NetIncomeLoss, 0001628280-23-005646 478.2M FY2020 FY2021 revenue 611.6M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-24-007670 FY2021 net income -158.3M · NetIncomeLoss, 0001628280-24-007670 611.6M FY2021 FY2022 revenue 717.8M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-25-008233 FY2022 net income -276.9M · NetIncomeLoss, 0001628280-25-008233 717.8M FY2022 FY2023 revenue 800.9M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-009869 FY2023 net income -96.9M · NetIncomeLoss, 0001628280-26-009869 800.9M FY2023 FY2024 revenue 860.8M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-009869 FY2024 net income -36.1M · NetIncomeLoss, 0001628280-26-009869 860.8M FY2024 FY2025 revenue 925.4M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-009869 FY2025 net income 28.8M · NetIncomeLoss, 0001628280-26-009869 925.4M FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2019 to FY2025 (6 years).

Growth per share, FY2018 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Book value per share -2.5% a year FY2022 $7.72 to FY2025 $7.15, 3 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 $0.11$7.15$0.41
Dec 31, 2024 -$0.18$7.34$0.25
Dec 31, 2023 -$0.49$7.56$0.30
Dec 31, 2022 -$1.53$7.72$0.03
Dec 31, 2021 ---
Jun 30, 2021 -$24.18-$128.51$4.64
Dec 31, 2020 ---
Jun 30, 2020 -$18.45-$111.37$3.04
Dec 31, 2019 ---
Jun 30, 2019 -$19.36$0.00-$0.29
Dec 31, 2018 ---

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $893.7M
  • − All liabilities $1.7B
  • = Net current asset value -$777.5M
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $1.9B
  • − Goodwill $1.9B
  • − Other intangible assets $606.3M
  • = Tangible book value -$612.3M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

MIR against Technology peers

Among the 233 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+6.2%+24.1%
+7.5%162nd of 231 · median +13.2%
Net margin
2.8%20.7%
2.7%175th of 229 · median 10.2%
Return on equity
3.1%24.0%
1.6%166th of 215 · median 12.7%
Free cash flow margin
8.4%27.8%
15.6%143rd of 226 · median 20.0%
Debt / equity (less is better)
1.020.25
0.2535th of 141 · median 0.52
MIR and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
MIR Mirion Technologies, Inc.$1.1B +7.5%48.1%2.7%1.6%15.6%0.25
SMTC Semtech Corp$1.1B +15.5%51.6%-3.0%-5.8%15.9%0.86
APPF Appfolio Inc$1.1B +19.7%-15.6%29.2%25.9%-
NOVT Novanta Inc$1.1B +3.3%44.5%4.9%3.3%12.9%0.51
ALRM Alarm.com Holdings, Inc.$1.1B +7.6%66.1%10.8%13.1%17.7%-
TENB Tenable Holdings, Inc.$1.1B +11.0%78.1%1.5%-26.3%-
All 233 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by product

From $925.4M of sales to $28.8M of profit FY2025

  • Product $690.6M
  • Service $234.8M
Revenue to Gross profit: $438.6MRevenue to Cost of revenue: $486.8MGross profit to Operating profit: $51.5MGross profit to Operating expenses: $387.1MOperating profit to Net profit: $28.8MOperating profit to Tax & other: $22.7MOperating expenses to R&D: $38.9MOperating expenses to SG&A: $348.2M Revenue: $925.4M REVENUE $925.4M +8% Y/Y Gross profit: $438.6M · 47% margin GROSS PROFIT $438.6M 47% margin · +10% Y/Y Cost of revenue: $486.8M · 53% of revenue COST OF REVENUE $486.8M 53% of revenue Operating profit: $51.5M · 6% margin OPERATING PROFIT $51.5M 6% margin · +108% Y/Y Operating expenses: $387.1M · 42% of revenue OPERATING EXPENSES $387.1M 42% of revenue Net profit: $28.8M · 3% margin NET PROFIT $28.8M 3% margin Tax & other: $22.7M · 2% of revenue TAX & OTHER $22.7M 2% of revenue R&D: $38.9M · 4% of revenue R&D $38.9M 4% of revenue SG&A: $348.2M · 38% of revenue SG&A $348.2M 38% of revenue

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2022 · 10-K XBRL, year-end balances

Return on equity 1.5% FY2022: -19.8% net income ÷ equity
Net margin 3.1% FY2022: -38.6% profit per $ of sales: 28.8M ÷ 925.4M
Asset turnover 0.26× FY2022: 0.26× sales per $ of assets: 925.4M ÷ 3.6B
Leverage 1.92× FY2022: 1.96× assets per $ of equity: 3.6B ÷ 1.9B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    2.7% vs 10.2%
  • Gross margin up over 5 years
    41.2% → 47.4%
  • Return on equity below 15%
    1.6%
  • A profit in 1 of 7 years
Net margin, FY2019 to FY2025: -27.7% to 3.1%

Balance sheet

  • Interest covered less than 5 times
    Operating income is 1.2× interest expense
  • Debt smaller than equity
    Debt / equity 0.25 on the latest balance sheet (peer median 0.52)
  • Current assets cover current liabilities
    Current ratio 3.02
  • Net debt under 3 years of free cash flow
    $35.3M net debt, 0.2 years
Debt / equity at each year end, FY2019 to FY2025: 0.58 to 0.24

Cash and shareholders

  • Free cash flow positive in 6 of 7 years
    $106.9M last year
  • Share count up over 5 years
    +3947.0%
  • Cash from operations above net income
    $143.3M vs $28.8M
Free cash flow, FY2019 to FY2025: -1.8M to 106.9M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Deferred revenue, current part

Paid in advance $121.8M cash received before delivery, not yet recognized as revenue, Sep 30, 2026 · +30.7% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

MIR's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue925.4M
FY2019: 440.1MFY2019: -FY2020: 478.2MFY2020: -FY2021: 611.6MFY2021: -FY2022: 717.8MFY2023: 800.9MFY2024: 860.8MFY2025: 925.4M FY2019FY2020FY2021FY2023FY2025
Net income28.8M
FY2019: -122.0MFY2019: -341FY2020: -119.1MFY2020: -45.3MFY2021: -158.3MFY2021: -158.4MFY2022: -276.9MFY2023: -96.9MFY2024: -36.1MFY2025: 28.8M FY2019FY2020FY2021FY2023FY2025
Free cash flow106.9M
FY2019: -1.8MFY2019: -FY2020: 19.6MFY2020: -FY2021: 30.4MFY2021: -FY2022: 5.2MFY2023: 58.1MFY2024: 50.3MFY2025: 106.9M FY2019FY2020FY2021FY2023FY2025
Free cash flow after stock pay91.7M
FY2019: -1.9MFY2019: -FY2020: 19.4MFY2020: -FY2021: 30.4MFY2021: -FY2022: -26.6MFY2023: 36.2MFY2024: 34.7MFY2025: 91.7M FY2019FY2020FY2021FY2023FY2025
EPS (diluted)0.11
FY2019: -19.36FY2019: -FY2020: -18.45FY2020: -FY2021: -24.18FY2021: -FY2022: -1.53FY2023: -0.49FY2024: -0.18FY2025: 0.11 FY2019FY2020FY2021FY2023FY2025
Diluted shares261.2M
FY2019: 6.3MFY2019: -FY2020: 6.5MFY2020: -FY2021: 6.5MFY2021: -FY2022: 181.1MFY2023: 196.4MFY2024: 205.0MFY2025: 261.2M FY2019FY2020FY2021FY2023FY2025

Revenue by business segment

year to Dec 31, 2025
RevenueSharevs year before
Nuclear & Safety 614.6M66.4% +9.5%
Medical 310.8M33.6% +3.7%

10-K 0001628280-26-009869, segment and revenue notes (XBRL).

Revenue by product or service

year to Dec 31, 2025
RevenueSharevs year before
Product 690.6M74.6% +7.4%
Service 234.8M25.4% +7.9%

10-K 0001628280-26-009869, segment and revenue notes (XBRL).

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
North America 582.2M62.9% +7.4%
United States 525.9M56.8% +5.6%
Europe 327.6M35.4% +7.2%
France 193.7M20.9% +6.7%
Asia Pacific 15.6M1.7% +20.0%

10-K 0001628280-26-009869, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Nuclear & Safety-446.1M516.4M561.1M614.6M
Medical155.7M271.7M284.5M299.7M310.8M
Technologies455.9M446.1M516.4M--

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Medical2.3M-98.9M13.0M--
Technologies68.1M-103.1M46.0M--
Corporate and other-59.2M-95.8M-80.9M--

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Segments changed: FY2021, FY2022, FY2023 are in italics, as first reported under the earlier segments, so they are not comparable with the later years. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2019FY2019FY2020FY2020FY2021FY2021FY2022FY2023FY2024FY2025
Revenue440.1M-478.2M-611.6M-717.8M800.9M860.8M925.4M
Cost of revenue251.9M-281.2M-359.8M-407.7M444.5M461.1M486.8M
Gross profit188.2M-197.0M-251.8M-310.1M356.4M399.7M438.6M
R&D14.0M-15.9M-29.4M-30.3M31.7M35.0M38.9M
SG&A145.4M341158.1M2.4M211.2M-362.3M340.1M341.1M348.2M
Operating income28.8M-23.0M-11.2M--297.8M-21.9M24.8M51.5M
Interest expense39.2M-39.2M-37.4M-37.1M61.9M57.9M42.2M
Pretax income-126.2M-341-124.6M-45.5M-164.3M--306.6M-105.3M-33.9M32.7M
Income tax-4.2M0-5.5M-266K-5.9M--18.2M-6.6M2.7M2.9M
Net income-122.0M-341-119.1M-45.3M-158.3M-158.4M-276.9M-96.9M-36.1M28.8M
EPS (diluted)-19.36--18.45--24.18--1.53-0.49-0.180.11
Diluted shares6.3M-6.5M-6.5M-181.1M196.4M205.0M261.2M
Depreciation & amortization69.5M-68.4M-83.6M-174.5M162.8M150.4M138.1M
EBITDA98.3M-91.4M-94.8M--123.3M140.9M175.2M189.6M
Gross margin42.8%-41.2%-41.2%-43.2%44.5%46.4%47.4%
Operating margin6.5%-4.8%-1.8%--41.5%-2.7%2.9%5.6%
Net margin-27.7%--24.9%--25.9%--38.6%-12.1%-4.2%3.1%
Revenue growth--+8.7%-+27.9%--+11.6%+7.5%+7.5%

Cash flow

From EDGAR
FY2019FY2019FY2020FY2020FY2021FY2021FY2022FY2023FY2024FY2025
Operating cash flow14.7M039.5M-945K53.6M-39.4M95.2M99.1M143.3M
Capital spending16.5M-19.9M-23.2M-34.2M37.1M48.8M36.4M
Free cash flow-1.8M-19.6M-30.4M-5.2M58.1M50.3M106.9M
Stock-based pay (added back)100K-200K-0-31.8M21.9M15.6M15.2M
Free cash flow after stock pay-1.9M-19.4M-30.4M--26.6M36.2M34.7M91.7M
Buybacks----0-00049.6M
Acquisitions9.1M-55.7M-290.1M-6.6M31.4M1.0M661.9M
Investing cash flow-25.6M--75.6M--313.3M--39.5M-64.7M-43.7M-694.6M
Financing cash flow15.0M0118.9M751.4M239.0M--7.0M22.6M-3.3M775.9M

Stock-based pay and leases

From EDGAR
FY2019FY2019FY2020FY2020FY2021FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)100K-200K-0-31.8M21.9M15.6M15.2M
Stock-based pay / revenue0.0%-0.0%-0.0%-4.4%2.7%1.8%1.6%
Operating lease cost--5.8M-9.9M9.9M9.8M10.7M12.5M9.4M
Operating lease cash paid------11.4M9.8M9.0M9.3M
Right-of-use assets--0-045.7M40.1M32.8M30.3M32.1M
Operating lease liabilities----52.1M49.9M43.3M34.9M33.5M34.5M
Finance lease liabilities-----900K500K200K0-

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MIR/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.